A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: Comment on the article by Maksymowych et al [6] (multiple letters)

Arthritis and Rheumatism

Volumn 48, Issue 2, 2003, Pages 583-584

  Singh, Ranju ^a   Menon, Yamini ^a   Cuchacovich, Raquel ^a   Espinoza, Luis R ^a   Maksymowych, Walter P ^b   Russell, Anthony S ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; ETANERCEPT; GLUCONATE CALCIUM; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHORUS; SALAZOSULFAPYRIDINE; VITAMIN D;

ADULT; ANKYLOSING SPONDYLITIS; ARTHRALGIA; BLOOD CELL COUNT; CASE REPORT; CERVICAL SPINE RADIOGRAPHY; CLINICAL FEATURE; DOSE RESPONSE; DRUG INFUSION; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; HYPOCALCEMIA; LETTER; MALE; MENTAL HEALTH; MYALGIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIPHOSPHONATES; DOUBLE-BLIND METHOD; HUMANS; HYPOCALCEMIA; MALE; RANDOMIZED CONTROLLED TRIALS; SPONDYLITIS, ANKYLOSING;

EID: 0037331213     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10717     Document Type: Letter

References (0)